![Colm Kelleher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 31 M $ op 30-09-2026
Colm Kelleher was a Director at Prosetta Biosciences, Inc. before obtaining an undergraduate and doctorate degree from Trinity College Dublin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
UBS Group AG
 UBS Group AG Investment ManagersFinance Provides private wealth management, advisory, investment and corporate banking & asset management services 0,02% | 31-12-2025 | 642.893 ( 0,02% ) | 31 M $ | 30-09-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
Prosetta Biosciences, Inc.
 Prosetta Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Prosetta Biosciences, Inc.
Prosetta Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
